A detailed history of Sovran Advisors, LLC transactions in Incyte Corp stock. As of the latest transaction made, Sovran Advisors, LLC holds 11,504 shares of INCY stock, worth $805,049. This represents 0.08% of its overall portfolio holdings.

Number of Shares
11,504
Previous 23,678 51.41%
Holding current value
$805,049
Previous $1.38 Billion 43.52%
% of portfolio
0.08%
Previous 0.18%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 09, 2025

SELL
$55.17 - $71.22 $671,639 - $867,032
-12,174 Reduced 51.41%
11,504 $778 Million
Q1 2025

Apr 24, 2025

BUY
$60.0 - $75.26 $1.42 Million - $1.78 Million
23,678 New
23,678 $1.38 Billion

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.6B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Sovran Advisors, LLC Portfolio

Follow Sovran Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sovran Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sovran Advisors, LLC with notifications on news.